Abstract
Background/Aim: Nasopharyngeal carcinoma (NPC) is more common in certain geographic regions and populations and is frequently diagnosed at advanced stages, highlighting the importance of identifying factors associated with survival.
Materials and Methods: Patients were selected from two previously conducted genome-wide association studies, resulting in a discovery cohort (n=314) and a validation cohort (n=135). Overall survival and disease-free survival were analyzed using Cox proportional hazards models adjusted for clinical covariates in both cohorts and a combined analysis of the data. Variants associated with survival in both cohorts (p<0.05) and showing consistent direction of effects were retained, and combined p-values are reported.
Results: The T allele of rs4671908, a variant located upstream of pleckstrin (PLEK) was linked to worse overall survival (hazard ratio=1.85, 95% confidence interval=1.48-2.32; p<10−7). The T allele of rs2238431, a variant located within adenylate cyclase 9 (ADCY9), was associated with poor disease-free survival (hazard ratio=1.73, 95% confidence interval=1.44-2.08; p<10−8). Both associations remained significant after Bonferroni correction. Functional annotation suggested that the T allele of rs4671908 was associated with increased PLEK expression and overlaps a predicted POU class 5 homeobox 1 (POU5F1)-binding site. The risky allele was more common in East Asian populations, consistent with the geographic distribution of NPC. The T allele of rs2238431 was associated with reduced expression of ADCY9.
Conclusion: This study identified rs4671908 and rs2238431 as germline variants associated with survival outcomes in NPC and provides epidemiological evidence that may inform future prognostic stratification of high-incidence populations.
- Nasopharyngeal carcinoma
- survival analysis
- germline variants
- genome-wide association study
- prognostic biomarkers
- cancer epidemiology
- Received March 4, 2026.
- Revision received April 11, 2026.
- Accepted April 14, 2026.
- Copyright © 2026 International Institute of Anticancer Research (Dr. George J. Delinasios), All rights reserved.
This article requires a subscription to view the full text. If you have a subscription you may use the login form below to view the article. Access to this article can also be purchased.






